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ABSTRACT
Objective: Pulmonary hypertension and right heart failure are poor 
prognostic factors in systemic sclerosis (SSc). The effect of cold 
stress on pulmonary vasospasm was evaluated in some trials but 
the results were conflicting. The aim of our study was to determine 
the effect of cold stress on right ventricular (RV) function.
Materials and Methods: Twenty-four patients with SSc and 
24 age and sex-matched healthy controls were enrolled in the 
study. Transthoracic echocardiography (TTE) was performed to 
all patients at rest and after peripheral cold exposure. Baseline 
and after cold stress test TTE results were compared between the 
groups.
Results: Cold exposure induced changes in particularly right 
venticular function. Pulmonary acceleration time was significantly 
shortened in the SSc group (118.8±11.7ms vs 111.3±13.7ms, 
P<0.001). Tricuspid annular plane systolic excurison and RV 
fractional area change were also decreased after cold exposure 
in the SSc group. (23.3±1.6mm vs 21.9±1.9 mm, P<0.001; 
46.3±5.8 vs 44.4±5.8,P= 0.007, consecutively). Left ventricular 
(LV) function did not change after cold stress (LV myocardial 
performance index (0.42± 0.04 vs 0.42± 0.05), P= 0.748).
Conclusion: Peripheral cold exposure caused a reduction 
in right ventricular function indicating pulmonary Raynaud’s 
phenomenon as a possible contributing factor.
Keywords: Systemic sclerosis, Echocardiography, Tissue Doppler, 
Right ventricular function
ÖZ
Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ 
kalp yetersizliği kötü prognoz göstergesidir. SSc’da soğuk stresin 
pulmoner vazospazm üzerine etkisi ile ilgili çeşitli çalışmalar 
yapılmış ancak sonuçlar çelişkili çıkmıştır. Bu çalışma ile SSc 
hastalarında periferik soğuk stresin sağ ventrikül fonksiyonuna 
etkisini araştırmayı amaçladık.
Gereç ve Yöntem: Yirmi dördü sklerodermalı, 24’ü sağlıklı 
toplam 48 kişi çalışmaya alındı. Her iki gruba istirahat ve periferik 
soğuk stres uygulama sonrasında transtorasik ekokardiyografi 
yapıldı. İstirahat ve soğuk stres sonrası sol ve sağ ventrikül 
fonksiyonu karşılaştırıldı.
Bulgular: Soğuk stresin özellikle sağ ventrikül fonksiyonunda 
değişikliğe yol açtığı görüldü. Pulmoner akselerasyon zamanı 
skleroderma grubunda anlamlı olarak kısaldı (118.8±11.7ms vs 
111.3±13.7ms, P<0.001). Triküspid anuler düzlem sistolik hareketi 
ve sağ ventrikül fraksiyonel alan değişimi de soğuk stres ile azaldı 
(23.3±1.6mm vs 21.9±1.9 mm, P<0.001; 46.3±5.8 vs 44.4±5.8,P= 
0.007, sırasıyla). Soğuk stres ile sol ventrikül fonksiyonunda 
değişiklik saptanmadı (sol ventrikül miyokard performans indeksi 
(0.42± 0.04 vs 0.42± 0.05), P= 0.748).
Sonuç: Periferik soğuk stres, sağ ventrikül fonksiyonunda 
azalmaya sebep olmuştur ve bu da pulmoner Raynaud fenomeninin 
pulmoner hipertansiyon gelişmesinde etken faktörlerden biri 
olabileceğini düşündürmektedir.
Anahtar kelimeler: Sistemik skleroz, Ekokardiografi, Doku 
Doppler, Sağ ventrikül fonksiyonu.
Introduction
Systemic sclerosis is a multisystemic connective tissue 
disease that causes vascular damage, and fibrosis in the 
skin and in the visceral organs [1,2]. Pulmonary and cardiac 
involvement are common in systemic sclerosis (SSc). 
Pulmonary hypertension (PHT) and right heart failure are 
poor prognostic factors. PHT has worse prognosis in patients 
with SSc than the other types of PHT [3,4]. Early detection 
of PHT and right ventricular impairment is very important 
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because clinical findings become obvious in the advanced 
stages of the disease. The etiology of PHT in SSc is not well 
understood. Raynaud’s phenomenon is the most common 
and cardinal feature of SSc  seen in about 90% of patients 
[5]. It is speculated that, the increased vasospastic response 
as in Raynaud’s phenomenon, can also be seen in pulmonary 
circulation and can be one of the contributing factors in the 
development of pulmonary hypertension [6-8].
In the present study, our aim was to investigate the 
effect of cold stress on right ventricular function using 
echocardiographic techniques.
Materials and Methods
Twenty four patients, followed by the Rheumatology Clinic 
and met the criteria for SSc as defined by the American College 
of Rheumatology [9], and 24 age-and sex-matched control 
subjects were included in the study. Patients with pacemaker 
implantation, heart failure, right or left bundle branch block, 
valvular heart disease, with known or suspected coronary 
heart disease and those using beta-blockers, prostacyclin 
analogs or ET-1 anatagonists were excluded; Ca – channel 
blocking agents were withheld one week before the study. 
All patients were in sinus rhythm and were asymptomatic 
in terms of heart failure and pulmonary hypertension. Six-
minute walking test was used to estimate the functional 
status of the patients and transthoracic echocardiographic 
examination was performed to all patients.
All patients gave written informed consent. The study 
protocol was approved by the Local Ethics Committee and 
the study was conducted in accordance with the Declaration 
of Helsinki.
Echocardiographic Examination
Transthoracic echocardiographic examinations (Vivid 7 Pro, 
GE, Horten, Norway, 2–4 Mhz phased-array transducer) 
were performed by one cardiologist. All the images were 
recorded digitally and the measurements were done offline 
by another experienced operator, who was blinded to the 
patients group. The average of three values were accepted as 
measurement. The resting echocardiographic examination 
was performed after the patients had rested for 10 minutes. 
Data were recorded from the average of three cardiac cycles. 
Following the baseline examination, cold stress was applied 
in a similar technique as the previous studies [10 ,11]. The 
patients’ right hand were immersed into cold water (5-10°C) 
up to ten minutes if tolerated. The echocardiographic 
measurements were recorded before the patients took their 
hands out of the cold water. All of the measurements were 
performed in accordance with the guidelines [12].
Left ventricle measurements: End-systolic and end-
diastolic diameters, septal and posterior wall thickness were 
measured from parasternal long axis view using M-mode. 
To calculate biplane left ventricle ejection fraction (LVEF) 
end-diastolic and end-systolic volumes were measured 
from apical long axis 4 chamber and 2 chamber views. 
Left atrium diameter was measured using M-mode from 
parasternal long view.
Right ventricle measurements: Right ventricle end-
diastolic and end-systolic area were measured from apical 
4 chamber view to calculate right ventricular fractional area 
change (RVFAC). Right ventricular free wall thickness was 
measured from subcostal view. Tricuspid annular plane 
systolic excursion ( TAPSE ) was measured by M-Mode 
echocardiography in the apical four chamber view.
Pulsed-wave Doppler measurements: To measure 
early (E) and late (A) diastolic wave peak velocities, mitral 
and tricuspid inflow patterns were obtained from an apical 
four chamber view. Pulmonary acceleration time (PAAT) 
was measured from right ventricular outflow tract Doppler 
recordings.
Tissue Doppler measurements: Pulsed-TDI volume 
samples were gathered from lateral side of LV annulus 
and free wall side of the RV. Peak systolic (S’), early (E’) 
and late (A’) diastolic velocities were obtained from the 
mitral lateral, and tricuspid free wall annuluses. Isovolumic 
relaxation time (IVRT), isovolumic contraction time (IVCT) 
and ejection time (ET) of both ventricles were measured. 
Left ventricle myocardial perfomance index (LVMPI) and 
right ventricle myocardial performance index (RVMPI) 
were calculated using the formula (IVCT+IVRT )/ ET.
Global ventricular function were assessed by myocardial 
performance index. We used PAAT, for estimation of 
pulmonary hypertension [13].
Pulmonary acceleration time, IVCT and IVRT, parameteres 
that associated with time, were adjusted according to heart 
rate using the formula that Bazett described (QTc = QT/√RR) 
for corrected QT mesurement [14].
Interobserver and intraobserver variability was assessed 
for PAAT, TAPSE and RV-IVRT from the recorded images 
of randomly chosen 10 patients.
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Statistical Analysis
Statistical analysis was performed by using SPSS 22.0. The 
distribution of variables were evaulated with Kolmogorov 
Smirnov test. Categorial data were given as counts 
(percentages) and were analyzed using the Chi-square test. 
All continuous variables were expressed as mean ± standard 
deviation or median (min-max) and analyzed with Mann-
Whitney U test or independent samples t test as appropriate. 
Baseline and cold stress echocardiographic measurements 
were compared using Wilcoxon t test. Inter-observer and 
intra-observer reliability were evaluated using interclass 
and intraclass correlation coefficients. P values <0.05 were 
accepted to indicate statistical significance.
Results
Baseline demographic and clinical characteristics
Demographic data of the subjects were given in Table I. The 
mean disease duration was 6.5±4.8 years (range, 1 – years). 
There were no differences between groups in terms of age, 
sex, body mass index (BMI), systolic and diastolic blood 
pressures, heart rate and six minute walking distance (P > 
0.05). 
Table I. Clinical and laboratory characteristics of the study 
population
Controls Scleroderma
(n=24) (n=24) P
Age (years) 44.3±8.0 46.8±12.3 0.160
Female/male, n/n 2/22 2/22 1
BMI, kg/m2 27±4.9 26.2±4.9 0.535
Heart rate, beats/m 80.2±11.0 79.8±8.8 0.812
SBP, mmHg 123.1±9.4 125.9±7.8 0.374
DBP, mmHg 68.2±6.4 71.3±6.5 0.131
Six-minute walking test, m 515.4±37.7 531.8±57.9 0.725
Disease duration, years - 6.5±4.8 -
ACE inhibitor,n 0 4 0.489
Oral antidiabetic,n 0 2 0.109
Statin,n 0 2 0.489
ACE: Angiotensin Converting Enzyme, BMI: Body mass index, SBP: 
Systolic blood pressure, DBP: Diastolic blood pressure.
Echocardiographic Characteristics
The resting echocardiographic values are given in Table II. 
LVEF, LV end-diastolic dimension, LV mass index, LA and 
RA dimensions, LV E/E’ and LV S’ were similar in both 
groups. LVMPI was significantly increased in the control 
group when compared to the SSc group (0.43(0.35-0.54) 
vs 0.34(0.27-0.41), P<0.001). None of the patients had 
tricuspid jet velocity more than 2.8m/s, but in about 30 % 
of the study population tricuspid jet could not be visualized.
Table  II. Resting echocardiographic characteristics of the study 
population.
Controls Scleroderma
(n=24) (n=24) P
LVEF, % 65.5 (58-77) 64.0(56-74) 0.305
LA diameter, mm 37.0 (26-40) 37.0 (28-43) 0.487
LVEDD, mm 46 (40-53) 45(38-53) 0.071
Septum thickness, mm 9 (7-10) 10(8-11) 0.138
PW, mm 9 (7-10) 9 (7-10) 0.228
LV mass, g/m2 73.5 (55-104) 74.8 (55-117) 0.415
LV E/E’ 5.4 (3-9) 6.0 (4-16) 0.056
LV MPI 0.34 (0.27-0.41) 0.43 (0.35-0.54) <0.001
RA diameter, mm 30.5 (25-36) 29.0 (27-31) 0.359
RV wall, mm 3.4 (3-4) 4.5 (3-6) <0.001
SPAP,mmHg 24.0 (20-29) 26.0 (24-35) 0.004
RVFAC, % 49.0 (41-58) 46.5 (34-56) <0.001
TAPSE, mm 26.0 (22-31) 23 (21-26) 0.002
RV IVCT, ms 48 (37-55) 57 (48-74) <0.001
RV S’, cm/s 15 (12-21) 13 (10-18) <0.001
RV MPI 0.31 (0.26-0.46) 0.42 (0.33-0.53) <0.001
RV IVRT, ms 41 (37-49) 59 (44-85) <0.001
PAAT, ms 140 (118-170) 120 (96-140) <0.001
E: Pulsed wave transmitral early diastolic velocity EF: Ejection fraction, 
E’: Early myocardial diastolic velocity, IVCT: Isovolumetric contraction 
time, IVRT: Isovolumetric relaxation time, LA: Left atrium, LVEDD: 
Left ventricle end diastolic diameter, LV:Left ventricle, MPI: Myocardial 
performance index, PAAT: pulmonary artery acceleration time. PW: 
Posterior wall, RA: Right atrium, RV: Right ventricle, RVFAC: Right 
ventricle fractional area change, S’: Systolic myocardial velocity, SPAP: 
Systolic pulmonary artery pressure, TAPSE: Tricuspid annular plane 
systolic excursion.
Pulmonary acceleration time, RVFAC, TAPSE and Rv S’ 
were all significantly reduced in patients with SSc (120(96-
140) vs 140(118-170) P<0.001, 46.5(34-56) vs 49(41-58), 
P=0.038, 23(21-26) vs 26(22-31) P=0.002, 13(10-18) vs 
15(12-21) P<0.001, respectively ). Additionally, IVCT and 
IVRT values were significantly higher in SSc group ( 57(48-
74) vs 48(37-55) P<0.001, 59(44-85) vs 41(37-49) P<0.001). 
RV MPI, which shows globally systolic and diastolic 
dysfunction, was also increased compared to control group 
(0.42(0.33-0.53) vs 0.31(0.26-0.46), P<0.001).
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Cold Stress
Cold stress echocardiographic measurements of the groups 
were given in Table III. RV systolic function changed in 
patients in the SSc group after cold stress (RVFAC, TAPSE, 
IVCT and PAAT), whereas no deterioration of RV function 
was observed in the control group. Left ventricular function 
was compared between the control group and SSc group 
during rest and after cold stress. There were no statistically 
significant differences in the left ventricular systolic 
and diastolic function in both groups during cold stress 
compared with the baseline values.
Reliability
Intra-observer reliability, as assessed by intra-class 
correlation coefficients for PAAT, RV IVRT and TAPSE, 
were respectively 0.96 ( 95% CI 0.85-0.99), 0.93 ( 95% 
CI 0.65-0.98) and 0.97 ( 95% CI 0.89-0.99). Inter-observer 
reliability, as assessed by inter-class correlation coefficients 
for PAAT, RV IVRT and TAPSE, were respectively 0.88 
( 95% CI 0.60-0.97), 0.86 ( 95% CI 0.52-0.96) and 0.96 
( 95% CI 0.86-0.99).
Discussion
The present study demonstrated that cold stress caused 
a reduction in right ventricular function indicating cold 
exposure may cause intermittent pulmonary vasospasm.
Myocardial involvement in SSc is associated with poor 
prognosis. Biventricular systolic and diastolic impairment 
has been shown in several studies [14-16]. The mechanism 
of right and left ventricle involvement can be different. 
Fibrosis due to collagen deposition is the main mechanism 
underlying left ventricular dysfunction, but interstitial lung 
disease and pulmonary hypertension also play an important 
role in the etiology of right ventricular dysfunction. 
Subclinical left ventricle dysfunction is not a rare finding 
[17-19]. In a recently published article of Spethmann 
et al., subclinical left ventricle impairment was shown 
using speckle-tracking echocardiography in patients with 
SSc [20]. Faludi et al., demonstrated that left ventricular 
diastolic dysfunction was highly prevalent in patients with 
SSc and was associated with increased risk of mortality 
[21]. In parallel with these studies, in the present study we 
also demonstrated that diastolic and systolic function of 
Table  III. Comparison of baseline and after cold stress echocardiographic data.
Control (n=24)  Scleroderma (n=24)
Rest Stress P Rest Stress P
HR, beats /m 80.2±11.0 82.3±11.7 <0.001 79.8±8.8 81.3±8.4 <0.001
PAAT, ms 142.0±13.5 141.0±15.4 0.116 118.8±11.7 111.3±13.7 0.001
PAATc, ms 163.4±15.6 161.9±17.5 0.544 136.6±13.8 127.9±16.1 <0.001
RVFAC,% 49.62±4.8 49.41±5.1 0.667 46.3±5.8 44.4±5.8 0.007
TAPSE, mm 25.75±2.77 25.70±2.70 0.909 23.3±1.6 21.9±1.9 <0.001
RV S’, cm/s 15.04±1.75 15.16±1.55 0.512 13.5±1.8 13.2±1.7 0.210
RV IVRT, ms 41.62±3.3 42.5±4.5 0.074 58.7±7.8 59.2±8.6 0.463
RV IVRTc, ms 47.4±3.7 47.3±3.3 0.629 67.5±9.9 67.2±9.4 0.794
RV IVCT, ms 47.0±4.6 47.7±3.7 0.069 58.9±7.0 61.8±7.7 0.009
RV IVCTc 54.3±7.0 55.4±6.5 0.110 68.2±10.2 69.1±9.4 0.217
RV MPI 0.31±0.04 0.32±0.04 0.084 0.41±0.04 0.42±0.04 0.149
LVEF,% 66.3±4.9 65.8±4.7 0.175 64.9±4.2 64.4±4.1 0.327
LVE/E’ 5.64±1.6 5.74±1.5 0.886 6.9± 2.6 6.9±2.10 0.548
LV S’, cm/s 8.5±1.74 8.37±1.61 0.328 8.70±0.7 8.40±0.7 0.262
LV MPI 0.34±0.04 0.35±0.04 0.635 0.42±0.04 0.42±0.05 0.748
E: Pulsed wave transmitral early diastolic velocity, E’: Early myocardial diastolic velocity, HR: Heart rate, IVCT: Isovolumetric contraction time, 
IVCTc: Isovolumetric contraction time corrected, IVRT: Isovolumetric relaxation time, IVRTc: Isovolumetric relaxation time corrected LV: Left 
ventricle, MPI: Myocardial performance index, PAAT: Pulmonary artery acceleration time, PAATc: Pulmonary artery acceleration time corrected, RV: 
Right Ventricle, RVFAC: Right ventricle fractional area change, RV S’: Right ventricle systolic myocardial velocity TAPSE: Tricuspid annular plane 
systolic excursion.
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the left ventricle, as shown by tissue Doppler derived MPI, 
were decreased compared to the control group.
Right ventricular dysfunction in SSC is associated 
with poor prognosis and have more prognostic relevance 
than left ventricular involvement [22]. It is usually due to 
pulmonary hypertension caused by vascular or interstitial 
lung disease, additionally ischemia and fibrosis are the other 
possible factors that cause right ventricular dysfunction. 
Durmus et al., used speckle-tracking echocardiography 
and showed right ventricular impairment in SSc patients 
without pulmonary hypertension [23]. Huez et al., also 
demonstrated right ventricular diastolic dysfunction and 
claimed latent pulmonary hypertension as a possible cause 
[24]. Lindqvist et al., studied right ventricular function in 
patients  with SSc and revealed impaired right ventricular 
diastolic function and reduced PAAT compared to control 
group [25]. Based on these results they implied that the 
cause of right ventricular diastolic impairment might be 
intermittent pulmonary hypertension.
There is exaggerated response to cold stimuli in SSc. 
Raynaud’s phenomenon (RP) is the cardinal feature of SSc. 
Similar to RP cold induced vasospasm was demonstrated in 
renal [26] and coronary arteries in a subgroup of patients 
[27-30]. Pulmonary hypertension develops in about 10-15 
% of patients with SSc. Repetitive pulmonary vasospasm 
has been affirmed as a possible mechanism of PHT in SSc. 
Whilst it is known that cold exposure increases sympathetic 
activation and systemic vascular resistance, the context of 
cold induced pulmonary vasospasm has not been proven 
yet [10]. Increased phosphodiesterase-1C expression and 
impaired production of prostaglandin I2 and an imbalance 
between prostaglandin I2 and thromboxane A2 were shown 
as the underlying mechanism of cold induced pulmonary 
vasospasm in patients with RP [31]. The effect of cold 
exposure on pulmonary circulation has been assessed in 
several studies with different methods and conflicting 
results. Several authors reported a reduction in the diffusing 
capacity of the lung for carbon monoxide (DLCO) [32,33]. 
They claimed that the decrease in DLCO after cold 
exposure indicated a reduction in capillary blood volume, 
suggesting pulmonary vasospasm. However, Lampert 
et al., also demonstrated a decrease in DLCO but also a 
reduction in mPAP and pulmonary vascular resistance, and 
pointed out that intrapulmonary blood redistribution may be 
the underlying mechanism that caused diminished DLCO 
[34]. Mukerjee et al., evaluated right ventricular function 
using cardiac catheterization after 2 minutes of cold stress, 
and found no differences whereas Sakamoto et al., found 
an increase in pulmonary hypertension in a subgroup of 
patients [11,8]. In a recently published study, Keir et al., 
implied pulmonary vasospasm as a possible explanation 
to worsening symptoms in a subgroup of patients after 
exposure to cold [6].
Detection of patients with cold induced pulmonary 
vasospasm and demonstrating the relation with overt 
pulmonary hypertension may provide a new perspective 
in the prevention of SSc related pulmonary hypertension. 
To the best of our knowledge, this is the first study 
investigating right venticular function after cold stress 
using echocardiography. In the present study, cold stimuli 
caused a significant reduction in the parameters of right 
ventricular systolic function, as TAPSE, RVFAC, IVCT and 
PAAT, however, there were no changes in left ventricular 
function after cold stress. One can argue that, whether such 
a short time of cold exposure can change RV function or 
not. Pulmonary circulation is a low pressure system and 
RV thickness is about 1/3 of LV, causing RV more sensitive 
to changes in afterload. Ischemia, fibrosis and pulmonary 
hypertension are the possible underlying mechanisms 
for the deterioration in right ventricular function in SSc, 
however as shown in the present study, solely decrease 
in RV function after cold stress, cannot be explained by 
cardiac Raynaud’s  phenomenon, ischemia or fibrosis. These 
results indicated that cold induced pulmonary vasospasm 
may be the cause of changes in RV function, however, 
further larger scale studies with follow-up are needed to 
put forth the association between intermittent pulmonary 
vasospasm and pulmonary hypertension and the underlying 
patophysiological mechanism.
The first limitation of our study is that we 
evaluated right ventricular function by transthoracic 
echocardiography. Despite all efforts, as in all studies based 
on echocardiography, echocardiograpic measurements have 
high intra and inter observer variability and we cannot 
exclude that the significant but small changes found in the 
present study could be a result of intra-observer variability. 
Cardiac MRI or right heart catheterization would have given 
us more objective data but we chose echocardiography since 
it is a non-invasive, and a low-cost method and can be used 
for screening. Novel echocardiographic techniques as strain 
imaging and 3D echocardiographic imaging could also be 
used, but unfortunately we did not have that opportunity. The 
second limitation of the present study is that, although the 
measurements were done offline by a cardiologist who was 
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blinded to the patients groups, the operator who performed 
the echocardiography was not blinded. The other important 
limitation of our study is small number of patients, and lack 
of follow-up of patients.
Conclusion 
Cold stress induced pulmonary RP may contribute to the 
development of PHT. Although, we were able to demonstrate 
that peripheral cold exposure caused a reduction in isolated 
right ventricular function by transthoracic echocardiography 
the lack of right heart catheterization or novel imaging 
modalities to assess right heart function, prevented us to 
imply more definitive conclusions. Further studies with 
larger sample size and follow-up are needed to detect the 
effects of cold stress on PHT and right heart function.
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